Why Biogen Stock Is Slipping Today
What happened
Shares of the biotech blueblood Biogen(NASDAQ:BIIB) are down by a hefty 7.42% as of 11:55 a.m. EDT on Thursday. That equates to about a $3.6 billion drop in the company’s market cap since the opening bell this morning.
Biogen’s shares are…
